HDAC8: A Promising Therapeutic Target for Acute Myeloid Leukemia

Histone deacetylase 8 (HDAC8), a class I HDAC that modifies non-histone proteins such as p53, is highly expressed in different hematological neoplasms including a subtype of acute myeloid leukemia (AML) bearing inversion of chromosome 16 [inv(16)]. To investigate HDAC8 contribution to hematopoietic...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Front Cell Dev Biol
Asıl Yazarlar: Spreafico, Marco, Gruszka, Alicja M., Valli, Debora, Mazzola, Mara, Deflorian, Gianluca, Quintè, Arianna, Totaro, Maria Grazia, Battaglia, Cristina, Alcalay, Myriam, Marozzi, Anna, Pistocchi, Anna
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Frontiers Media S.A. 2020
Konular:
Cell and Developmental Biology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7498549/
https://ncbi.nlm.nih.gov/pubmed/33015043
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcell.2020.00844
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller